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Introduction
We present our stereotactic radiotherapy (SRT)
comparison between the Gamma Knife (GK) installed
at Barrow Neurological Institute (BNI) in 1997, and the
CyberKnife (CK) installed at BNI in 2003, as a series of
tables. Firstly though, we present a brief historical
overview of SRT including the concept of skull mounted
surgical guidance, radiotherapy methods using radium
sources which pre-date SRT by several decades, SRT
growth points and the American Society for Therapeutic
Radiology & Oncology/American College of Radiology
(ASTRO/ACR) definition of SRT.
Stereotactic defined
Chamber’s English Dictionary of 1988 [1] defines the
prefix stereo- as ‘in composition, solid, hard, three-
dimensional’ and the word stereotactic as ‘relating to the
precise location of particular brain structures by three-
dimensional survey’. Whereas Dorland’s Medical
Dictionary of 1988 [2] defines stereotactic (alternatively
stereotaxic) as ‘pertaining to or characterised by precise
positioning in space; said especially of discrete areas of
the brain that control specific functions’. With reference
to radiotherapy probably the earliest use of the word
stereotaxic was by Lars Leksell in 1951 [3] when he used
it in conjunction with the term radiosurgery.
The adjective ‘stereotactic’ as applied to a fixation
frame was referred to by Barton Guthrie & John Adler
[4] when they described Robert Clarke’s stereotactic
frame for animal use, the last prototype of which was
sold to Johns Hopkins University in 1920. Clarke was of
the opinion that ‘from its application to animals to its
adaption to human surgery is a long step …. but … for my
own part, I have no doubt that its application to human
surgery will only be a question of time‘. The term
‘stereotaxic approach’ was coined by Clarke at the
beginning of the 20th century [5].
Concept of skull mounted surgical guidance
The concept of skull mounted surgical guidance was
suggested in the 19th century. The Russian anatomist
Zernov, using the anthropologic concept of craniotomy,
designed a head frame on which were mounted a set of
arcs that he used to map and measure human cerebral
gyri. In 1887, Minor & Altuchov used the device on
several patients to localise and remove cortical surface
lesions. This combination of craniotomy and functional
cerebral localisation proved adequate for finding gross
intracranial pathologies but the patients died due to
inadequate surgical and medical technology [6].
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Radium and radon for cranial therapy
By the end of the 1930s brain tumours had been treated
by external beam radiotherapy, either using X-ray
machines or teleradium machines termed radium bombs,
or by several radium sources positioned on a cap or
helmet worn by the patient and made of material such as
leather or Colombia paste. Radium needles or radium
tubes actually implanted within brain tissue (interstitial
radium brachytherapy) were rare, although a few
examples are recorded. One example is the attempt by
Harvey Cushing as early as 1923, but he was not
impressed with the results and did not pursue the method
[7, 8].
Another example, in 1929, was by Sir Henry Souttar
[9] surgeon to The London Hospital. He treated an
angioma of the meninges where the skull flap had
a central hole made so that radium needles could be
withdrawn at the end of treatment. Six needles were used,
each of 2 cm length and 2 mg radium activity. Souttar’s
conclusion was ‘a new field of surgery is opening up
before us, the limits of which it is impossible to see’ [9].
However, neither Cushing nor Souttar used
stereotactic head frames and it was not until the 1950s
that such frames were introduced into radiotherapy
practice, and then only for the limited application of
radon seed implants to the pituitary. When artificially
produced radionuclides became available after World
War II for medical use, radon seeds were replaced in the
1960s by small 90Yttrium rod sources. 90Yttrium is a pure
beta emitting radionuclide with a maximum energy of
2.25 MeV and a half-life of 64.2 hours [10]. Then came
Lars Leksell, the Gamma Knife, linear accelerator based
stereotactic radiotherapy using a head frame, and the
CyberKnife: and the rest, as one might say, is now history.
Growth points in SRT
Table I lists the important growth points in SRT from
Lars Leksell’s original Gamma Unit of 1951 to the first
clinical use, at Stanford University in 1994 of the
CyberKnife.
Conformal SRT features
By the end of the 1980s the limitations of frame-based
cranial SRT were becoming more apparent. The major
challenge was increasingly seen as the development of
a method to treat lesions using conformal SRT that would
provide the following features. 1. Elimination of the need
for frame fixation. 2. Ability to relate the identified lesion
to radiographic markers and anatomical landmarks. 3.
Allow for near real-time image acquisition and tracking.
It was realised that if these three features could be
incorporated into a SRT system it would then be possible
using SRT to deliver treatment to any location within the
body and to compensate for body, organ and lesion
motion during treatment. Also, fractionated treatment
would be possible. This development was finally attained
with the CyberKnife system [4, 22].
ASTRO/ACR guide to radiation oncology coding
The ASTRO/ACR Guide to Radiation Oncology Coding
2005 [23] defines SRT as the ‘Delivery of an ablative level
of radiation to a particular lesion, typically in the brain,
with high precision. SRT is usually delivered in a high
dose single fraction, through multiple fractions at smaller
dose levels across days or weeks, or through hyper-
fractionated dose multiple times in one day to minimise
normal tissue damage’.
The Guidelines also define stereotactic body
radiation therapy (SBRT) as a ‘newly emerging radio-
therapy treatment method to deliver a high dose of
radiation to a target, utilising either a single dose or
a small number of fractions with a high degree of
precision within the body’.
Initially SRT was used only to treat intracranial
lesions in a single fraction and was termed stereotactic
radiosurgery (SRS). However, more recent SRT platforms
have allowed this technique to be applied to all body sites
and to be used in either a single or hypofractionated
treatment regime and therefore SRS is more appropria-
tely referred to as SRT or SBRT. We use SRT.
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Table I. SRT growth points
Year Author SRT growth point
1951 Leksell Description of technique & treatment of first patient: Stockholm [3]
1958 Larsson 185 MeV proton beam used for SRT: Uppsala [11]
1967 Leksell First Gamma Unit patient treated [12]
1974 Larsson Isocentric linear accelerators proposed as viable sources for SRT [13] 
1975 Leksell Second generation Gamma Unit developed [14]
1983 Betti First linear accelerator modified for SRT: Buenos Aires [15, 16]
1985 Colombo Non-coplanar converging arcs technique introduced clinically: Vicenza [17] 
and in Heidelberg by Hartmann [18]
1986 Lutz First non-coplanar linear accelerator based SRT in  North America:
Harvard, Boston [19] and McGill, Montreal by Podgorsak [20, 21]
1991 Adler Concept of the CyberKnife described [4]
1994 Adler First intracranial lesion treated with CyberKnife [22]
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Gamma Knife system
BNI is one of relatively few institutions which has both
Gamma Knife and CyberKnife systems. Our Gamma
Knife SRT patient workload is given in Table II. The
CyberKnife system was installed later because of the
limitation of frame based SRT with the Gamma Knife.
These limitations are given in Table III and possible
sources of inaccuracy for frame based SRT are indicated
in Table IV. Figure 1 shows an example of a patient whom
it was impossible to treat using the frame based Gamma
Knife.
CyberKnife system
The ultimate solution to the problem of frame
deformation would be to abandon the frame completely,
applying fiducials directly to the cranium. With the
CyberKnife system this is exactly what has been achieved,
i.e., the abandonment of any necessity for a stereotactic
frame. Our CyberKnife patient workload is given in Table
V and CyberKnife features in Table VI. Table VII lists
possible sources of inaccuracy in image guided frameless
SRT.
Table V. BNI CyberKnife patients treated October 2003 to March 2005
Disease/condition No. of cases
Intracranial
Brain metastases 33
Malignant glial tumours 17
Meningiomas 33
Pituitary and acoustic 21
Other 17
Extracranial





Table VI. CyberKnife features
– A new set of images is acquired and analysed at each independently
targeted linear accelerator beam position/node
– A feedback loop between the robotic arm and the imaging system
adjusts the targeting of the linear accelerator beam to compensate
for patient or target movement during treatment: since with the
– CyberKnife, patient or target movement can be detected
– The interval between imaging acquisition and linear accelerator
repositioning is 4-10 seconds
– A typical SRT case might be 6-30 Gy delivered to the PTV margin
generated from 100-300 intersecting beams
Table III. Frame based SRT limitations
– There is pain at the pin sites and during the post-operative recovery. This requires an anaesthesiologist, a nurse and patient monitoring
– Some lesions are either impossible or extremely difficult to treat because of their location. This is due to technical limitations which can cause
collisions of frame or patient with hardware
– Same day imaging is required
– Fractionated treatments are difficult and uncomfortable for the patient
– Unable to treat extracranial lesions
– Imaging during treatment is not possible
– Detection and analysis of patient or target movement during treatment is not possible
Table IV. Possible sources of inaccuracy in frame based SRT




Mechanical coupling and adjustment
– Mechanical limitations of SRT frames: factors dependent upon the properties of the frame [25]
Rigidity and the perfect immobilisation of the patient’s head within the reference frame
Mechanical properties of the frame’s construction: engineering design and the materials used
Mechanical loads on the frame due to the weight of the patient’s head and shoulders, possibly
resulting in physical deformation of the frame
– Patient positioning errors due to positioning changes: supine to prone [25]
Table II. BNI Gamma Knife patients treated March 1997
to August 2004
Disease/condition No. of cases
Metastatic to brain 715
Benign tumours 587
Glial tumours 405
Functional (Trigeminal neuralgia) 337
Vascular 149
Miscellaneous skull base 63
Total 2256
Table VII. Possible sources of inaccuracy in image-guided frameless SRT
– Image data management
Registration and import of images into the treatment planning
system
Fusion and scaling of MR, CT, angiography and PET images
– CT/MRI slice protocols
Image resolution
Geometrical fidelity of the images
Edge softening, blurring from reconstruction
Other operator dependent ambiguities in delineation of structures
Volumetric accuracy of scanner
– Beam delivery accuracy
Robotic positioning fidelity
Patient couch positioning and stability
Gamma Knife and CyberKnife comparisons:
advantages and disadvantages
With the image-based frameless CyberKnife SRT system,
its accuracy and precision has been reported by Chang et
al [26] to have values within one voxel of the imaging
study. Since then resolution results of less than 1 mm
have been reported by Yu et al [27]. Errors affecting
clinical accuracy are those relating to anatomical
targeting, stereotactic localisation and treatment delivery.
The achievable clinical accuracy for SRT for the different
systems are given in Table VIII. Our assessment of the
advantages and disadvantages of Gamma Knife and
CyberKnife systems are listed in Table IX and Table X.
Table VIII. Achievable clinical accuracy for SRT systems [24, 25]
SRT system Accuracy (mm)
CyberKnife 0.7
Gamma Knife 1.7
Gantry linear accelerator 2.0
128
Figure 1. Example of a patient whose lesion could not be fully treated using the frame based Gamma Knife SRT system. This was due to location of
the lesion and would have resulted in head frame collision with the collimator
Table IX. Advantages and disadvantages of Gamma Knife SRT
Advantages
– Evidence-based optimisation of dose response and outcomes based
on more than 30 years of clinical experience
– Fast treatment planning
– Arteriovenous malformation (AVM) treatment is equivalent to SRT
using CyberKnife without angiography image fusion
– Well established trigeminal neuralgia SRT with MRI images
(CyberKnife requires a cisternogram)
– Same day therapy: treatment completed in less than one week
– System reliability and very little down time
Disadvantages
– Frame placement
– Staffing requirements: nursing and anaesthesiolog
– No real-time imaging: no intra-treatment motion compensation
– No extracranial applications, only limited to brain/skull SRT
– Fractionation impracticable
– Schedule flexibility is limited: inefficient time use during the
treatment day
– Cost of replacement of 60Cobalt sources every 5-6 years
– Old technology
Limited on lesion size
No inverse treatment planning
No inhomogeneity corrections
Table X. Advantages and disadvantages of CyberKnife SRT
Advantages
– All body locations, both cranial and extracranial, can be treated
– Fractionation possible
– CT image-based treatment planning
– Ability to track and correct for patient or lesion movement
– Inverse treatment planning software
– No requirements for a frame or for anaesthesia, nursing or other
ancillary staff
– Flexible sequential scheduling possible for patients
Disadvantages
– Evolving software. Image fusion and planning are time consuming
– Fiducial placement required for spine and body sites
– CT imaging requirement for treatment planning and motion
tracking
– Immature clinical data and lack of clinical trials
– Unknown optimal dose-fractionation scheme
– Unknown optimal PTV for extracranial sites
– Scheduling coordination for treatment planning and delivery




Now that at BNI we have both the CyberKnife and
Gamma Knife systems we have assessed which are the
optimum groups of patients for SRT using the two
systems, Table XI. This is based on our findings presented
in the previous tables of this paper.
Table XI. Preferred SRT workload subdivision between CyberKnife
and Gamma Knife at BNI
CyberKnife Gamma Knife
– Spines – AVMs
– Extracranial sites – Trigeminal neuralgia
– Perichiasmal – Rapid treatments
– Cranial nerves – Out-of-town patients
– Brain stem
– Extreme intracranial locations
– Patient preference
John J. Kresl MD, PhD
Department of Radiation Oncology,
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